Lanperisone
- Level
- Commodity
- Parent
- 51152000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51152034This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TO2JP2G53H. European Medicines Agency schedules Lanperisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08400MIG. Lanperisone generally arises in the molecular formula C15H18F3NO. The term LANPERISONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35.) LANPERISONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lanperisone under HS 29339990 and SITC 51577. As of Q4 2014, LANPERISONE remains the US FDA Preferred Term for this commodity. Lanperisone bears US NLM identifiers UMLS ID C2697881 and NCI Concept Code C79785. SMILES: FC(F)(F)C1CCC(C(=O)C(CN2CCCC2)C)CC1.
Same parent
Under 51152000 · 74Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.